PDCD1 and cancer: In addition, two case reports of HIV-infected patients treated for cancer with anti-CTLA-4 antibody [47] or anti-PD1 antibody [48] have recently shown a good safety profile, as confirmed in two series of patients treated for melanoma (n = 9) [49] and lung cancer (n = 10) [50].